Skip to main content
Article
Recurrent autoimmune hemolytic anemia in splenic marginal zone lymphoma.
J Community Hosp Intern Med Perspect
  • Oreoluwa Oladiran, Reading Hospital-Tower Health
  • Rashmi Dhital, Reading Hospital-Tower Health
  • Anthony Donato, Reading Hospital-Tower Health
Document Type
Article
Publication Date
8-23-2018
Abstract

Autoimmune hemolytic anemia (AIHA) is a condition associated with an extensive differential diagnosis that includes lymphoid malignancies. Although AIHA occurs in about 10-25% of patients with chronic lymphocytic leukemia, it is also reported to occur in all of the other lymphoid subtypes. In this article, we report a case of recurrent AIHA in a 67-year-old woman with two acute episodes of hemolysis separated by 3 years of hematologic remission. Both episodes were severe enough to require blood transfusion, oral steroids, and rituximab. Bone marrow biopsy and immunophenotyping using flow cytometry done during both admissions confirmed the presence of splenic marginal zone lymphoma.

Citation Information
Oreoluwa Oladiran, Rashmi Dhital and Anthony Donato. "Recurrent autoimmune hemolytic anemia in splenic marginal zone lymphoma." J Community Hosp Intern Med Perspect Vol. 8 Iss. 4 (2018) p. 244 - 245
Available at: http://works.bepress.com/anthony-donato/17/